Asymmetric dimethyl arginine as a cardiovascular risk marker in patients with hyperthyroidism: a randomised case control study in a tertiary level health care centre

Journal Title: International Journal of Clinical Biochemistry and Research - Year 2017, Vol 4, Issue 1

Abstract

Background: Cardiovascular manifestations are frequent findings in patients with thyroid hormone disorders. Asymmetric dimethylarginine (ADMA), a inhibitor of endothelial nitric oxide synthase (eNOS), blocks nitric oxide (NO) synthesis from l-arginine. So, ADMA level can be considered as cardiovascular risk marker as it is a possible contributing factors for endothelial dysfunction in hyperthyroid patients. Objectives: The aim of the study was to assess ADMA levels in hyperthyroidism patients free of cardiovascular risk associates and further comparison with healthy controls. Methodology: The study took place in Victoria Hospital, attached to Bangalore Medical College and Research Institute. The study groups consisted of 30 patients with diagnosed hyperthyroidism and 30 healthy sex and age matched controls. The patients with renal failure, diabetes and severe hypertension were excluded. ADMA was estimated by double-antibody sandwich enzyme-linked immunosorbent assay (ELISA). Results: The Mean ADMA level was higher in the hyperthyroid group (1.1346±0.6382μmol/L) than in the control group (0.584±0.2377μmol/L) and it was statistically significant (p<0.0001). Conclusion: ADMA represents a new and well-characterized marker that has been associated with many traditional and novel risk factors in the setting of cardiovascular risk. So, an elevation of ADMA levels of patients with hyperthyroidism compared with healthy controls may contribute to some cardiovascular alterations.

Authors and Affiliations

Priyanka Patra, Anitha M. , HL Vishwanath

Keywords

Related Articles

Usefulness of serum gamma glutamyl transferase in assessing severity of preeclampsia

Introduction: Pre-eclampsia is a multisystem disorder, unique to pregnant women after twenty weeks of gestation. In India the incidence of pre-eclampsia is reported to be 8-10% of the pregnancy. It contributes significan...

A study of pre-analytical variables and quality improvement in testing process of clinical laboratory

Introduction: Laboratory tests are important to diagnose the diseases, to monitor the progress and to see the response to the treatment of patients. Pre-analytical variables include specimen collection, timing, transport...

Study of serum ferritin and HbA1c in type 2 diabetes mellitus

Introduction Diabetes is a metabolic disorder characterized by hyperglycaemia which is associated with rise in the HbA1c Excess iron damages cells of pancreas due to oxidative stress which can contribute to pathogenesis...

Comparison of LDL-cholesterol estimated by various formulae with directly measured LDL-cholesterol in a tertiary care centre of Maval Taluka

Introduction Lowdensity Lipoprotein Cholesterol LDLC concentration in blood gives indication of cardiovascular disease risk LDLC may vary at various strata of Triglycerides and in metabolic diseases like Diabetes Mellitu...

A study of preanalytical errors in a hospital based clinical biochemistry laboratory and recommendation of required corrective measures

Background & Objective: The errors associated with the total testing process in laboratory, affecting clinical decision making, may occur at the pre-analytical, analytical and post-analytical phase. This study is aimed a...

Download PDF file
  • EP ID EP295935
  • DOI 10.18231/2394-6377.2017.0023
  • Views 97
  • Downloads 0

How To Cite

Priyanka Patra, Anitha M. , HL Vishwanath (2017). Asymmetric dimethyl arginine as a cardiovascular risk marker in patients with hyperthyroidism: a randomised case control study in a tertiary level health care centre. International Journal of Clinical Biochemistry and Research, 4(1), 99-102. https://europub.co.uk/articles/-A-295935